Objective: To describe atrophic changes of the hippocampus and entorhinal cortex in
frontotemporal dementia (FTD) and compare them with those of AD. Background: The …

It is not well known whether Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers
are associated with brain damage in cognitively normal elderly. The combined influence of …

Alzheimer's disease (AD) is characterized by progressive dementia and distinct
neuropathology at autopsy. In order to test the relationship between dementia severity and …

We evaluated three groups of elderly individuals who were carefully screened to rule out
clinically significant diseases that could affect cognition. They were matched for age and …

The term early-onset Alzheimer's disease (EOAD) identifies patients who meet criteria for
AD, but show onset of symptoms before the age of 65. We map progression of gray matter …

Alzheimer's disease (AD) has a slow onset, so it is challenging to distinguish brain changes
in healthy elderly persons from incipient AD. One-year brain changes with a distinct …

Objective: A large cohort of subjects with mild cognitive impairment (MCI) was categorized
into tertiles based on hippocampal atrophy rates, as a proxy for Alzheimer-type pathology …

The aims of this study were to investigate the pattern of cortical atrophy and the relationships
between memory performances and the brain regions in Alzheimer's Disease (AD) …

There is compelling evidence for the early involvement of the hippocampal formation in the
natural history of Alzheimer's disease (AD). The evidence comes from recent …

The relative contribution of Alzheimer's disease (AD) hippocampal neuronal pathology in
cognitive decline is still a matter of debate. To address this issue, we performed a …